CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters
- 1 March 1992
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 12 (3), 223-227
- https://doi.org/10.1002/pd.1970120312
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- First‐trimester maternal serum alpha‐fetoprotein and human chorionic gonadotropin screening for chromosome defectsPrenatal Diagnosis, 1990
- First‐trimester maternal serum biochemical indicators in Down syndromePrenatal Diagnosis, 1990
- Very high CA 125 levels during early first trimester in three cases of spontaneous abortion with chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1990
- Maternal serum markers in screening for Down syndromeClinical Genetics, 1990
- Maternal serum AFP levels in the first trimester of pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1989
- The distribution of CA 125 in the reproductive tract of pregnant and non‐pregnant womenBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988
- CA 125 antigen in human amniotic fluid and fetal membranesAmerican Journal of Obstetrics and Gynecology, 1986
- Increased Serum Ca 125 Levels During the First Trimester of PregnancyActa Obstetricia et Gynecologica Scandinavica, 1986
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981